Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 4.58 MB)

  Published:

  16 December 2021

• Final appraisal determination committee papers (PDF 1.47 MB)

  Published:

  16 December 2021